Phenominer Database Results (12 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
ACI/SegHsd percentage of study population developing benign colorectal tumors during a period of time 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 75.0 % ex vivo light microscopy 0.0 0 70376 1378
WF/CrCrli benign colorectal tumor number 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 0.25 null 0.14 0.62 ex vivo light microscopy 0.0 0 70377 1378
WF/CrCrli well differentiated malignant colorectal tumor number 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 0.16 null 0.04 0.19 ex vivo light microscopy 0.0 0 70382 1378
WF/CrCrli percentage of study population developing benign colorectal tumors during a period of time 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 25.0 % ex vivo light microscopy 0.0 0 70375 1378
ACI/SegHsd benign colorectal tumor number 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 1.5 null 0.31 1.4 ex vivo light microscopy 0.0 0 70378 1378
ACI/SegHsd well differentiated malignant colorectal tumor number 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 0.28 null 0.04 0.16 ex vivo light microscopy 0.0 0 70381 1378
WF/CrCrli poorly differentiated malignant colorectal tumor number 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 1.08 null 0.06 0.29 ex vivo light microscopy 0.0 0 70385 1378
WF/CrCrli percentage of study population developing poorly differentiated malignant colorectal tumors during a period of time 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 80.0 % ex vivo light microscopy 0.0 0 70383 1378
WF/CrCrli poorly differentiated malignant colorectal tumor number 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 0.21 null 0.05 0.22 ex vivo light microscopy 0.0 0 70386 1378
WF/CrCrli percentage of study population developing well differentiated malignant colorectal tumors during a period of time 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 15.0 % ex vivo light microscopy 0.0 0 70379 1378
ACI/SegHsd percentage of study population developing well differentiated malignant colorectal tumors during a period of time 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 20.0 % ex vivo light microscopy 0.0 0 70380 1378
ACI/SegHsd percentage of study population developing poorly differentiated malignant colorectal tumors during a period of time 1,2-dimethylhydrazine (20 mg/kg/week) (for 182 days) De Miglio MR, et al., Carcinogenesis. 2007 May 17;. colorectal integrity trait not specified 0 days 20 15.0 % ex vivo light microscopy 0.0 0 70384 1378